Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunity
D. Kim, G. Biancon, Z. Bai, J. VanOudenhove, Y. Liu, S. Kothari, L. Gowda, J. M. Kwan, N. C. Buitrago-Pocasangre, N. Lele, H. Asashima, M. K. Racke, J. E. Wilson, T. S. Givens, M. M. Tomayko, , R. Fan
The paper develops a microfluidic immuno-serology assay to analyze immune responses in patients with altered immunity, finding reduced diversity in protein cooperation and impaired antibody responses in certain groups.
bioRxiv · Aug 31, 2022 · PreprintBioengineering